Shawn Tomasello
Director/Board Member at ALLOVIR, INC.
Net worth: 53 572 $ as of 29/06/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sol Barer | M | 76 | 37 years | |
| Theresa Janke | F | 49 | 11 years | |
| Michael Amoroso | M | 46 | 4 years | |
| David Kirn | M | 62 | 11 years | |
| James N. Campbell | M | 76 | 11 years | |
| Steven Nichtberger | M | 62 | 7 years | |
| Juan Vera | M | 44 | 11 years | |
| Diana Brainard | M | 53 | 5 years | |
| Anup Marda | M | 46 | 5 years | |
| Fariborz Kamal | M | 61 | 6 years | |
| Niranjan Y. Sardesai | M | 56 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 7 years |
| Elizabeth Barrett | F | 61 | 5 years | |
| Malcolm Brenner | M | 72 | 12 years | |
| Paul Hughes | M | - | 5 years | |
| Dong Kim | M | 47 | 3 years | |
| Scott Bizily | M | 52 | 3 years | |
| Noriyuki Kasahara | M | 62 | 2 years | |
| Jeffrey Kindler | M | 68 | 11 years | |
| Vikas Sinha | M | 60 | 6 years | |
| Samik Basu | M | - | 5 years | |
| Peter Olagunju | M | - | 3 years | |
| Philip Krause | M | - | 2 years | |
| Jason Smith | M | 52 | 4 years | |
| Greg Gin | M | - | 4 years | |
| Gill Marshall | M | - | 4 years | |
| Joann Peters | F | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 5 years |
| Catherine Bollard | M | 56 | 5 years | |
| Julian Pei | M | - | - | |
| John Milligan | M | 63 | 4 years | |
| Derek Adams | M | 50 | 1 years | |
| Ann M. Leen | M | 47 | 11 years | |
| Charles Theuer | M | 60 | 8 years | |
| William Bertrand | M | 59 | 1 years | |
| Philip Facchina | M | 62 | 3 years | |
| Susannah Gray | F | 63 | 4 years | |
| Morana Jovan-Embiricos | M | 57 | 5 years | |
| David Hallal | M | 56 | 6 years | |
| Michael Gerard | M | 44 | 3 years | |
| Jeffrey Bornstein | M | 57 | 4 years | |
| Wulff-Erik von Borcke | M | - | 9 years | |
| Mary Coelho | F | 62 | 1 years | |
| Jacob Chacko | M | 45 | 5 years | |
| Mark Simon | M | 62 | 6 years | |
| Edward Miller | M | 59 | 5 years | |
| Nancy Miller-Rich | F | 65 | 4 years | |
| Richard Henriques | M | 68 | 5 years | |
| Scott Brun | M | 56 | 3 years | |
| Robert Kim | M | 63 | 4 years | |
| Martha O'Connor | F | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sean Whelan | M | 53 | 6 years | |
| Ian Clark | M | 62 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 14 years |
| Ansbert Gadicke | M | 66 | 8 years | |
| Jacqualyn Fouse | M | 62 | 7 years | |
| Robert Duggan | M | 79 | 7 years | |
| John Wilson | M | 64 | 9 years | |
| Jonathan Biller | M | 61 | 8 years | |
| Arie Belldegrun | M | 74 | 8 years | |
| Ramses Erdtmann | M | 60 | 6 years | |
| Clarissa Desjardins | M | 57 | 8 years | |
| Atul Kavthekar | M | 56 | 2 years | |
| Phil Hagerman | M | 71 | 45 years | |
| Julian Adams | M | 69 | 8 years | |
| Gary Rice | M | 66 | 8 years | |
| Roy Hardiman | M | 64 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 25 years |
| Garry Menzel | M | 59 | 7 years | |
| David Schaffer | M | 53 | 9 years | |
| Gil Hakim | M | 54 | 8 years | |
| Scott Smith | M | 61 | 10 years | |
| Charlie Harrison | M | - | 9 years | |
| Benjamin Wolin | M | 49 | 5 years | |
| Diane Parks | F | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Abbey Jenkins | F | - | 2 years | |
| Robert A. Swanson | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Christopher Chai | M | 58 | 7 years | |
| Timothy Moore | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
| David Tanen | M | 52 | - | |
| Peter Kellogg | M | 67 | 5 years | |
| Perry Karsen | M | 69 | 9 years | |
| Alan Colowick | M | 61 | 10 years | |
| Manmeet Singh Soni | M | 46 | 3 years | |
| Peter Pfreundschuh | M | 55 | 2 years | |
| Louis Lavigne | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| David Bonita | M | 48 | 6 years | |
| Patrick Baeuerle | M | 66 | 6 years | |
| Joao Siffert | M | 60 | 2 years | |
| Stephen Webster | M | 63 | 3 years | |
| Thomas Daniel | M | 70 | 10 years | |
| Heather DiVecchia | F | - | 6 years | |
| Stephen B. Howell | M | 79 | 24 years | |
| Jeffrey Park | M | 52 | 2 years | |
| August Moretti | M | 73 | 4 years | |
| Christine Cassiano | F | - | 1 years | |
| Michael E. Flowers | M | - | 2 years | |
| David C. Dreyer | M | 67 | 6 years | |
| Thomas E. Michaels | M | - | 6 years | |
| George Manor | M | - | 2 years | |
| Karen Peterson | F | - | - | |
| Phillip Eric Lee | M | 37 | 3 years | |
| Paul L. Jenkinson | M | 64 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Australia | 4 | 4.00% |
| Canada | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shawn Tomasello
- Personal Network
